Lars Minor
Directeur Général chez NEWBURY PHARMACEUTICALS AB
Profil
Lars Minor is currently the Chief Executive Officer at Newbury Pharmaceuticals AB since 2021.
Prior to this, he worked as the Vice President-Strategy & Execution at LEO Pharma A.
Mr. Minor completed his undergraduate degree from Copenhagen Business School.
Postes actifs de Lars Minor
| Sociétés | Poste | Début |
|---|---|---|
| NEWBURY PHARMACEUTICALS AB | Directeur Général | 01/01/2021 |
Anciens postes connus de Lars Minor
| Sociétés | Poste | Fin |
|---|---|---|
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
Formation de Lars Minor
| Copenhagen Business School | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEWBURY PHARMACEUTICALS AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
